STATE STREET CORP - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 208 filers reported holding NOVAVAX INC in Q1 2024. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of NOVAVAX INC
ValueSharesWeighting
Q2 2024$76,797,826
-5.0%
6,066,179
-64.1%
0.00%
-25.0%
Q1 2024$80,813,405
+0.4%
16,906,570
+0.8%
0.00%0.0%
Q4 2023$80,524,200
+9.3%
16,775,875
+64.9%
0.00%0.0%
Q3 2023$73,664,227
-15.1%
10,174,617
-12.9%
0.00%
-20.0%
Q2 2023$86,778,150
+12.8%
11,679,428
+5.2%
0.01%
+25.0%
Q1 2023$76,941,191
-38.4%
11,102,625
-8.6%
0.00%0.0%
Q4 2022$124,933,210
+87.8%
12,153,036
+232.5%
0.00%0.0%
Q3 2022$66,529,000
-56.4%
3,655,428
+23.2%
0.00%
-55.6%
Q2 2022$152,586,000
-17.0%
2,966,864
+18.9%
0.01%0.0%
Q1 2022$183,797,000
-32.4%
2,495,542
+31.4%
0.01%
-30.8%
Q4 2021$271,721,000
-25.0%
1,899,220
+8.7%
0.01%
-31.6%
Q3 2021$362,093,000
+0.7%
1,746,627
+3.1%
0.02%0.0%
Q2 2021$359,524,000
+37.5%
1,693,390
+17.4%
0.02%
+26.7%
Q1 2021$261,440,000
+35.8%
1,441,953
-16.5%
0.02%
+25.0%
Q4 2020$192,487,000
+4.0%
1,726,182
+1.0%
0.01%
-7.7%
Q3 2020$185,155,000
-4.0%
1,708,859
-26.1%
0.01%
-7.1%
Q2 2020$192,817,000
+2349.7%
2,313,347
+299.1%
0.01%
+1300.0%
Q1 2020$7,871,000
+363.0%
579,632
+35.7%
0.00%
Q4 2019$1,700,000
-20.2%
427,076
+0.7%
0.00%
Q3 2019$2,129,000
-11.4%
424,189
+3.4%
0.00%
Q2 2019$2,403,000410,1230.00%
Other shareholders
NOVAVAX INC shareholders Q1 2024
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 493,650$55,047,0006.79%
RA Capital Management 3,788,564$422,463,0005.91%
Foresite Capital Management I, LLC 66,810$7,450,0003.92%
HELLMAN JORDAN MANAGEMENT CO INC /MA/ 10,000$1,115,0003.54%
TSP Capital Management Group, LLC 50,075$5,584,0001.98%
Foresite Capital Management II, LLC 67,373$7,513,0001.98%
Healthcare Value Capital, LLC 5,000$558,0001.88%
SECTORAL ASSET MANAGEMENT INC 223,350$24,906,0001.76%
WBI INVESTMENTS, LLC 96,619$10,774,0001.63%
Ikarian Capital, LLC 323,700$36,097,0001.59%
View complete list of NOVAVAX INC shareholders